Esperion Therapeutics, Inc. (ESPR) Social Stream
ESPERION THERAPEUTICS INC (ESPR) Price Targets From Analysts
Use the tables below to see what analysts covering ESPERION THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 8 | $114 | $8 | $35.375 | $1.33 | 2559.77% |
| 2021-12-09 | 8 | $90 | $8 | $22.625 | $1.33 | 1601.13% |
| 2021-12-22 | 8 | $90 | $5 | $22.125 | $1.33 | 1563.53% |
| 2021-12-23 | 8 | $30 | $5 | $13.75 | $1.33 | 933.83% |
| 2022-01-05 | 8 | $30 | $5 | $13.5 | $1.33 | 915.04% |
| 2022-01-11 | 8 | $30 | $5 | $12.875 | $1.33 | 868.05% |
| 2022-01-21 | 8 | $30 | $4 | $12.5 | $1.33 | 839.85% |
| 2022-01-28 | 8 | $27 | $4 | $10.625 | $1.33 | 698.87% |
| 2022-01-31 | 8 | $27 | $4 | $10.25 | $1.33 | 670.68% |
| 2022-02-25 | 8 | $27 | $4 | $10.857 | $1.33 | 716.32% |
| 2022-03-10 | 9 | $27 | $4 | $12.25 | $1.33 | 821.05% |
| 2022-05-04 | 8 | $27 | $4 | $12.857 | $1.33 | 866.69% |
| 2022-05-05 | 8 | $27 | $5 | $12.25 | $1.33 | 821.05% |
| 2022-08-03 | 8 | $27 | $3 | $11.444 | $1.33 | 760.45% |
| 2022-10-12 | 8 | $27 | $3 | $11.222 | $1.33 | 743.76% |
| 2022-11-02 | 8 | $27 | $3 | $11.333 | $1.33 | 752.11% |
| 2022-11-09 | 8 | $27 | $3 | $12 | $1.33 | 802.26% |
| 2022-12-07 | 7 | $22 | $3 | $9.857 | $1.33 | 641.13% |
| 2022-12-20 | 8 | $22 | $3 | $9.75 | $1.33 | 633.08% |
| 2023-01-10 | 8 | $22 | $3 | $9.75 | $1.33 | 633.08% |
| 2023-02-22 | 8 | $22 | $3 | $9.75 | $1.33 | 633.08% |
| 2023-02-24 | 9 | $22 | $3 | $10.5 | $1.33 | 689.47% |
| 2023-03-06 | 9 | $22 | $3 | $10.625 | $1.33 | 698.87% |
| 2023-03-16 | 10 | $22 | $1 | $10.15 | $1.33 | 663.16% |
| 2023-03-17 | 10 | $22 | $1 | $9.55 | $1.33 | 618.05% |
| 2023-03-24 | 10 | $22 | $1 | $9.6 | $1.33 | 621.8% |
| 2023-04-18 | 10 | $22 | $1 | $9.2 | $1.33 | 591.73% |
| 2023-05-09 | 9 | $22 | $1 | $9.8 | $1.33 | 636.84% |
| 2023-05-11 | 9 | $22 | $1 | $9.244 | $1.33 | 595.04% |
| 2023-06-06 | 8 | $22 | $1 | $10.025 | $1.33 | 653.76% |
| 2023-06-26 | 7 | $22 | $1 | $10.571 | $1.33 | 694.81% |
| 2023-08-01 | 7 | $22 | $1 | $10.571 | $1.33 | 694.81% |
| 2023-11-08 | 7 | $22 | $2 | $8.857 | $1.33 | 565.94% |
The Trend in the Analyst Price Target
Over the past 13 months, ESPR's average price target has gone down $0.94.
ESPR reports an average of 430.17% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-08 | 8 | 22 | 3.0 | 9.750 | 6.30 | 54.76% |
| 2023-03-16 | 10 | 22 | 1.5 | 10.550 | 1.82 | 479.67% |
| 2023-03-28 | 10 | 22 | 1.0 | 9.200 | 1.76 | 422.73% |
| 2023-04-18 | 10 | 22 | 1.0 | 9.888 | 1.32 | 649.09% |
| 2023-05-11 | 9 | 22 | 1.0 | 10.025 | 1.49 | 572.82% |
ESPR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 5 | 1 | 2 | 1 | 1 | 9 |
The Trend in the Broker Recommendations
Over the past 23 months, ESPR's average broker recommendation rating improved by 1.26.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ESPR as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, ESPERION THERAPEUTICS INC's variance in analysts' estimates is lower than -4042.96% of them.
- ESPERION THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 4017.64% of stocks in the mid market cap category.
- ESPR has a higher average analyst price target than 584.59% of stocks in the mid market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ESPERION THERAPEUTICS INC's number of analysts covering the stock is higher than 2464.96% of them.
Stocks similar to ESPERION THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PBYI, PCRX, and EBS.
View All Top Stocks by Price Target
What is the outlook for ESPR? Use POWR Ratings for clearer insight into price direction.